Related Experiment Video

Updated: May 30, 2025

Analysis of Targeted Viral Protein Nanoparticles Delivered to HER2+ Tumors
11:52

Analysis of Targeted Viral Protein Nanoparticles Delivered to HER2+ Tumors

Published on: June 18, 2013

11.0K

Correction: Novel targeted mtLivin nanoparticles treatment for disseminated diffuse large B-cell lymphoma

Ihab Abd-Elrahman1, Taher Nassar2, Noha Khairi1,3

  • 1Department of Hematology, Hadassah Medical Organization, Jerusalem, Israel.

Oncogene
|January 29, 2025
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Enhancing Tumor Content through Tumor Macrodissection
10:04

Enhancing Tumor Content through Tumor Macrodissection

Published on: February 12, 2022

9.7K
Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles
08:03

Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles

Published on: December 1, 2016

9.0K

Related Experiment Videos

Last Updated: May 30, 2025

Analysis of Targeted Viral Protein Nanoparticles Delivered to HER2+ Tumors
11:52

Analysis of Targeted Viral Protein Nanoparticles Delivered to HER2+ Tumors

Published on: June 18, 2013

11.0K
Enhancing Tumor Content through Tumor Macrodissection
10:04

Enhancing Tumor Content through Tumor Macrodissection

Published on: February 12, 2022

9.7K
Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles
08:03

Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles

Published on: December 1, 2016

9.0K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.4K

Articles linked to this work by shared authors, journal, and citation graph.

CD74-Targeted Cathepsin-Inhibitor Antibody-Drug Conjugate Triggers Apoptosis in DLBCL.

Cells·2026

Doxorubicin-Loaded Nanoparticle Treatment Enhances Diffuse Large B-Cell Lymphoma Cell Death.

Cells·2025

Novel targeted mtLivin nanoparticles treatment for disseminated diffuse large B-cell lymphoma.

Oncogene·2020

POC1A promotes the proliferation, metastasis and stemness of bladder cancer by stabilizing BMI1 via USP7.

Oncogene·2026

Frequently amplified SHANK2 promotes esophageal squamous cell carcinoma progression through the DVL/YAP axis.

Oncogene·2026

Neuromedin U 'innervation' reprograms myeloid immunosuppression in neuroendocrine prostate cancer.

Oncogene·2026

DHCR24+ tumor epithelial cells drive cisplatin resistance in bladder cancer by enhancing cholesterol metabolism to activate lipid raft-associated MAPK signaling.

Oncogene·2026

SEC14L2 contributes to tumor progression by enhancing USP5-driven RBM3 deubiquitination in pancreatic ductal adenocarcinoma.

Oncogene·2026

Decitabine suppresses triple-negative breast cancer by disrupting DNMT1 liquid-liquid phase separation and synergizes with G9a inhibition.

Oncogene·2026

[Current Status and Challenges in the Regulation of Weight Management Medical Devices].

Zhongguo yi liao qi xie za zhi = Chinese journal of medical instrumentation·2026

Amenamevir Transfer into Breast Milk in Patients with Herpes Simplex Virus Infection: A Brief Report of a Prospective Multicenter Study.

The Journal of dermatology·2026

Performance of large language models as a source of clinical information on bacteriophage therapy.

Npj viruses·2026

Mannose-decorated nanostructured lipid carriers improve the intracellular activity of antitubercular drugs against Mycobacterium tuberculosis.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026

Poly (Lipoic Acid) Nanoparticles With High Blood-Brain Barrier Permeability and Enhanced Anti-Ferroptotic Activity for Ischemic Stroke Treatment.

Small (Weinheim an der Bergstrasse, Germany)·2026

Low-intensity pulsed ultrasound-mediated nose-to-brain co-delivery of β-blockers and aPD-L1 enhances glioblastoma immunotherapy.

Nature communications·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us